Efficacy and safety of CFTR modulators in patients with interstitial lung disease caused by ABCA3 transporter deficiency

Authors

S. Marchand‐Adam (ORCID: https://orcid.org/0000-0002-9522-3738)
Nadia Nathan (ORCID: https://orcid.org/0000-0001-5149-7975)
Lise Morer
Marie Legendre (ORCID: https://orcid.org/0000-0003-2178-0846)
Justine Frija‐Masson (ORCID: https://orcid.org/0000-0001-5575-3913)
Camille Louvrier (ORCID: https://orcid.org/0000-0003-2105-1117)
Mwetty Onanga
Séverine Feuillet
Isabelle Fajac (ORCID: https://orcid.org/0000-0002-1532-1486)
Bruno Crestani (ORCID: https://orcid.org/0000-0002-2961-3455)
Raphaël Borie (ORCID: https://orcid.org/0000-0002-9906-0024)
Marie‐Pierre Debray (ORCID: https://orcid.org/0000-0003-2109-5662)
Pierre‐Régis Burgel (ORCID: https://orcid.org/0000-0003-0903-9828)
Mathilde Le Brun (ORCID: https://orcid.org/0009-0007-1906-453X)

Institutions

Inserm (FR)
Université Paris Cité (FR)
Sorbonne Université (FR)
Hôpital Armand-Trousseau (FR)
Sorbonne Paris Cité (FR)
Hôpital Cochin (FR)
Centre Hospitalier Universitaire de Tours (FR)
Assistance Publique – Hôpitaux de Paris (FR)
Hôpital Marie Lannelongue (FR)
Hôpital Bichat-Claude-Bernard (FR)
NeuroDiderot (FR)
Maladies génétiques d’expression pédiatrique

Publication Details

Journal: ERJ Open Research
Published: 2024-11-07
DOI: https://doi.org/10.1183/23120541.00701-2024
Citations: 5
Primary Topic: Cystic Fibrosis Research Advances
Type: article
Field-Weighted Citation Impact: 2.09

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Efficacy and safety of CFTR modulators in patients with interstitial lung disease caused by ABCA3 transporter deficiency

S. Marchand‐Adam, Nadia Nathan, Lise Morer, Marie Legendre et al.

Nov 7, 2024

5 citations

ERJ Open Research

Cystic Fibrosis Research Advances

2.09

article

Efficacy and safety of CFTR modulators in patients with interstitial lung disease caused by ABCA3 transporter deficiency

S. Marchand‐Adam, Nadia Nathan, Lise Morer, Marie Legendre, Justine Frija‐Masson, Camille Louvrier, Mwetty Onanga, Séverine Feuillet, Isabelle Fajac, Bruno Crestani, Raphaël Borie, Marie‐Pierre Debray, Pierre‐Régis Burgel, Mathilde Le Brun

November 7, 2024article en

5 citations

Abstract

No abstract available for this paper.

ERJ Open ResearchVol. 11(2)

Inserm (FR), Université Paris Cité (FR), Sorbonne Université (FR), Hôpital Armand-Trousseau (FR), Sorbonne Paris Cité (FR), Hôpital Cochin (FR), Centre Hospitalier Universitaire de Tours (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Marie Lannelongue (FR), Hôpital Bichat-Claude-Bernard (FR), NeuroDiderot (FR), Maladies génétiques d’expression pédiatrique

Good health and well-being

Openalex Percentile: Top 12%

Cystic Fibrosis Research Advances

2.09

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of CFTR modulators in patients with interstitial lung disease caused by ABCA3 transporter deficiency — S. Marchand‐Adam, Nadia Nathan, et al. · ERJ Open Research (2024) | TGRS Research Map | TGRS